Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 9 | 2023 | 2149 | 1.070 |
Why?
|
Lactams | 1 | 2023 | 156 | 0.840 |
Why?
|
Leucine | 1 | 2023 | 548 | 0.800 |
Why?
|
Proline | 1 | 2023 | 455 | 0.780 |
Why?
|
Ritonavir | 1 | 2023 | 329 | 0.770 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2019 | 29 | 0.640 |
Why?
|
Nitriles | 1 | 2023 | 971 | 0.610 |
Why?
|
Uterine Diseases | 1 | 2019 | 108 | 0.600 |
Why?
|
Mycoplasma genitalium | 1 | 2016 | 12 | 0.540 |
Why?
|
Mycoplasma Infections | 1 | 2016 | 120 | 0.520 |
Why?
|
Puerperal Disorders | 1 | 2019 | 300 | 0.520 |
Why?
|
Tuberculin Test | 1 | 2016 | 206 | 0.500 |
Why?
|
Benchmarking | 1 | 2021 | 1045 | 0.460 |
Why?
|
Prenatal Care | 2 | 2019 | 1140 | 0.450 |
Why?
|
Circumcision, Female | 1 | 2012 | 32 | 0.400 |
Why?
|
Bacteremia | 1 | 2019 | 977 | 0.390 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 1048 | 0.380 |
Why?
|
Pregnancy | 19 | 2024 | 29868 | 0.370 |
Why?
|
Antiviral Agents | 1 | 2023 | 3039 | 0.370 |
Why?
|
Fever | 1 | 2019 | 1618 | 0.370 |
Why?
|
Travel | 1 | 2017 | 796 | 0.370 |
Why?
|
Chorioamnionitis | 2 | 2023 | 156 | 0.350 |
Why?
|
Developing Countries | 2 | 2021 | 2867 | 0.320 |
Why?
|
Mass Screening | 2 | 2020 | 5424 | 0.230 |
Why?
|
Tuberculosis | 1 | 2016 | 2015 | 0.210 |
Why?
|
Genes, MHC Class I | 1 | 2002 | 235 | 0.190 |
Why?
|
HIV-2 | 1 | 2002 | 156 | 0.190 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 111 | 0.180 |
Why?
|
Anesthesia, Spinal | 1 | 2022 | 279 | 0.170 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 24 | 0.160 |
Why?
|
Inflammation | 1 | 2019 | 10760 | 0.160 |
Why?
|
Maternal Health Services | 1 | 2024 | 460 | 0.150 |
Why?
|
Labor, Obstetric | 1 | 2021 | 323 | 0.150 |
Why?
|
Peripartum Period | 1 | 2019 | 137 | 0.150 |
Why?
|
Senegal | 4 | 2020 | 255 | 0.140 |
Why?
|
Arbovirus Infections | 1 | 2017 | 21 | 0.140 |
Why?
|
Decision Trees | 1 | 2019 | 504 | 0.140 |
Why?
|
Parturition | 1 | 2021 | 447 | 0.140 |
Why?
|
Papillomavirus Vaccines | 1 | 2023 | 496 | 0.140 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2021 | 1351 | 0.140 |
Why?
|
Hypotension | 1 | 2022 | 878 | 0.140 |
Why?
|
Abortion, Induced | 1 | 2022 | 461 | 0.140 |
Why?
|
Female | 24 | 2024 | 392148 | 0.130 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3351 | 0.130 |
Why?
|
Sharks | 1 | 2015 | 21 | 0.130 |
Why?
|
Immunization | 1 | 2019 | 1217 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 745 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 767 | 0.120 |
Why?
|
Infant, Newborn | 5 | 2022 | 26180 | 0.120 |
Why?
|
Medicine | 1 | 2022 | 942 | 0.110 |
Why?
|
Fetal Blood | 1 | 2020 | 1347 | 0.110 |
Why?
|
Delivery, Obstetric | 1 | 2021 | 939 | 0.110 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7402 | 0.110 |
Why?
|
Conservation of Natural Resources | 1 | 2015 | 208 | 0.110 |
Why?
|
Gynecology | 1 | 2019 | 526 | 0.110 |
Why?
|
Tilapia | 1 | 2012 | 24 | 0.100 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14648 | 0.100 |
Why?
|
Obstetrics | 1 | 2019 | 666 | 0.100 |
Why?
|
Cesarean Section | 1 | 2021 | 1396 | 0.100 |
Why?
|
HIV Infections | 2 | 2012 | 17337 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2019 | 1389 | 0.090 |
Why?
|
Placenta | 1 | 2020 | 1709 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1611 | 0.090 |
Why?
|
Retrospective Studies | 6 | 2023 | 80566 | 0.090 |
Why?
|
Humans | 23 | 2024 | 760617 | 0.090 |
Why?
|
Data Collection | 1 | 2019 | 3315 | 0.090 |
Why?
|
Emigrants and Immigrants | 1 | 2016 | 544 | 0.080 |
Why?
|
Antibodies, Viral | 1 | 2020 | 3150 | 0.080 |
Why?
|
Water Pollutants, Chemical | 1 | 2012 | 359 | 0.080 |
Why?
|
Urban Population | 1 | 2016 | 2033 | 0.080 |
Why?
|
Prevalence | 3 | 2021 | 15689 | 0.070 |
Why?
|
Postpartum Period | 2 | 2023 | 1178 | 0.060 |
Why?
|
Environmental Monitoring | 1 | 2012 | 1460 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7389 | 0.060 |
Why?
|
Adult | 7 | 2024 | 220969 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
HLA-B35 Antigen | 1 | 2002 | 7 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Risk Factors | 3 | 2019 | 74115 | 0.050 |
Why?
|
Gene Products, gag | 1 | 2002 | 312 | 0.050 |
Why?
|
HIV Antigens | 1 | 2002 | 325 | 0.050 |
Why?
|
Abortion, Legal | 1 | 2022 | 113 | 0.050 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 206 | 0.050 |
Why?
|
Communication Barriers | 1 | 2024 | 414 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20074 | 0.040 |
Why?
|
Vaccination | 2 | 2023 | 3370 | 0.040 |
Why?
|
Incidence | 1 | 2019 | 21337 | 0.040 |
Why?
|
United States | 4 | 2024 | 72272 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2002 | 17878 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15251 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2022 | 22148 | 0.040 |
Why?
|
Cohort Studies | 2 | 2020 | 41457 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2020 | 131 | 0.040 |
Why?
|
Young Adult | 3 | 2024 | 59179 | 0.040 |
Why?
|
Influenza A virus | 1 | 2020 | 458 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2023 | 64568 | 0.030 |
Why?
|
Attitude of Health Personnel | 2 | 2022 | 3879 | 0.030 |
Why?
|
Career Mobility | 1 | 2019 | 259 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1526 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1022 | 0.030 |
Why?
|
Fisheries | 1 | 2015 | 48 | 0.030 |
Why?
|
HIV Antibodies | 1 | 2002 | 1302 | 0.030 |
Why?
|
Gene Frequency | 1 | 2002 | 3601 | 0.030 |
Why?
|
Adolescent | 3 | 2024 | 88234 | 0.030 |
Why?
|
Salinity | 1 | 2012 | 12 | 0.030 |
Why?
|
Career Choice | 1 | 2019 | 756 | 0.030 |
Why?
|
Body Size | 1 | 2015 | 463 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2012 | 90 | 0.030 |
Why?
|
Hemodynamics | 1 | 2022 | 4160 | 0.030 |
Why?
|
RNA, Viral | 1 | 2020 | 2838 | 0.020 |
Why?
|
Seawater | 1 | 2012 | 124 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2446 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2544 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3325 | 0.020 |
Why?
|
Alleles | 1 | 2002 | 6861 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26049 | 0.020 |
Why?
|
Polychlorinated Biphenyls | 1 | 2012 | 236 | 0.020 |
Why?
|
Glutathione Transferase | 1 | 2012 | 565 | 0.020 |
Why?
|
Animals | 3 | 2017 | 168201 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 42188 | 0.020 |
Why?
|
Child | 2 | 2020 | 80079 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2024 | 4321 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4533 | 0.020 |
Why?
|
Spine | 1 | 2015 | 1112 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8426 | 0.020 |
Why?
|
Ecosystem | 1 | 2012 | 487 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8833 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7798 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54360 | 0.020 |
Why?
|
Disease Progression | 1 | 2002 | 13495 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2022 | 5430 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15828 | 0.010 |
Why?
|
Male | 4 | 2020 | 360358 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10704 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8645 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36152 | 0.010 |
Why?
|
Internship and Residency | 1 | 2019 | 5878 | 0.010 |
Why?
|
Middle Aged | 2 | 2024 | 220584 | 0.010 |
Why?
|
Concepts
(139)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(57)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_